Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Cancer Drugs

Targeted drug delays relapse of intermediate-stage lung cancer

A drug holds lung cancer at bay longer after surgery than standard chemotherapy, according to unpublished results of a new trial in China.

Blocking growth of tumour blood vessels could boost immunotherapy

Immunotherapy treatment could be improved by blocking molecules that help tumour blood vessels grow, according to two new lab-based studies.

Naturally occurring symptoms may be mistaken for tamoxifen side-effects

Women taking tamoxifen to prevent breast cancer were less likely to continue taking the drug if they suffered nausea and vomiting, according to new data.

Cancer cells hijack healthy cells to regrow after treatment

Chemotherapy can cause some of the healthy cells surrounding a tumour to make proteins that encourage hardy tumour cells to start growing again

Drug that targets stem cells could help treat leukaemia

A new drug that can kill specialised stem cells could lead to a new treatment for a type of leukaemia.

Scientists discover drug combination slows lung cancer cell growth

Scientists have shown that a drug combination slows cancer cell growth in a type of non-small cell lung cancer when tested in the lab.

Bubbly drinks inspire more effective cancer treatment

Cancer Research UK scientists are developing a bubbly drink packed with oxygen microbubbles to make treatments more potent for hard to treat tumours.

Giving chemotherapy after radiotherapy improves survival for patients with rare brain tumour

Giving chemotherapy after radiotherapy delays further growth of a rare type of brain tumour, increasing the number of patients alive at five years.

Scientists tear down pancreatic cancer's defences

Glasgow researchers have shown an experimental drug that blocks CXCR2 can improve survival in mice when given with immunotherapy drugs.

Scientists identify possible double whammy to attack leukaemia

Cancer Research UK scientists have identified a potential double drug combination against B-cell acute lymphoblastic leukaemia.

Pages